Aprepitant vs. Desloratadine in EGFR-TKIs Related Pruritus Treatment
Condition: Non-small Cell Lung CancerInterventions: Drug: Aprepitant and placebo; Drug: desloratadine and placeboSponsor: Sun Yat-sen UniversityActive, not recruiting - verified January 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials